Results 31 to 40 of about 5,801,365 (309)

Therapeutic drug monitoring of immunosuppressant drugs in Marmara University Hospital [PDF]

open access: yes, 2004
Immunosuppressive therapy is the most crucial treatment of organ-transplanted patients. Both cyclosporin and tacrolimus have become a part of the standard immunosuppressive therapy for prevention of rejection.
AKICI, AHMET   +3 more
core   +1 more source

Therapeutic Drug Monitoring of Voriconazole [PDF]

open access: yesTherapeutic Drug Monitoring, 2008
Voriconazole is a triazole antifungal developed for the treatment of life-threatening fungal infections in immunocompromised patients. The drug, which is available for both oral and intravenous administration, has broad-spectrum activity against pathogenic yeasts, dimorphic fungi, and opportunistic molds.
Bruggemann, R.J.M.   +7 more
openaire   +3 more sources

Therapeutic drug monitoring in Turkey: Experiences from Istanbul

open access: yes, 2000
Therapeutic drug monitoring (TDM) has assumed an important place in patient management in the last few decades. In this study, serum drug levels determined in 7759 specimens sent to the Department of Pharmacology and Clinical Pharmacology in 1994 and ...
OZEK, Mehmet   +3 more
core   +1 more source

Posaconazole therapeutic drug monitoring in a regional hospital setting

open access: yes, 2016
Background: Posaconazole therapeutic drug monitoring (TDM) is recommended to promote effective antifungal prophylaxis, but its utility has yet to be optimized. Breakthrough invasive fungal infections have been reported with serum concentrations
Patrick J. Lindsay   +9 more
core   +1 more source

Therapeutic Drug Monitoring of Antibiotics Is Needed in the Treatment of Sepsis

open access: yesВестник анестезиологии и реаниматологии, 2022
The article presents the results of a prospective one-center observational clinical study.The level of therapeutic drug monitoring antibiotics was studied in patients with sepsis.The objective: to assess the impact of pharmacokinetics and ...
G. P. Plotnikov   +7 more
doaj   +1 more source

Therapeutic Drug Monitoring of Antibody Drugs

open access: yesBiological and Pharmaceutical Bulletin, 2022
In recent years, many antibody drugs that play an important role in the pharmacotherapy of several diseases have been developed. Antibody drugs exhibit immunogenicity in vivo leading to the development of antibodies against the antibody drug (anti-drug antibody). Nonetheless, other factors also affect the pharmacokinetics of antibody drugs.
openaire   +2 more sources

Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC

open access: yes, 2001
Reboxetine isa new antidepressant drug acting as a potent and selective noradrenaline reuptake inhibitor on the noradrenergic neuronal system. Because of an expected interindividual variability in drug metabolism in the clinical practice the need for ...
Peterson, Curt,   +3 more
core   +1 more source

Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting

open access: yes, 2002
When Efexor® (venlafaxine) became available in Sweden, a therapeutic drug monitoring (TDM) service was developed in the authors' laboratory. This analytical service was available to all physicians in the country.
Reis, Margareta,   +3 more
core   +2 more sources

Pharmacometrics modeling and simulation to assist phenobarbital dose optimization in dogs

open access: yesFrontiers in Veterinary Science
IntroductionPhenobarbital (PB) remains the first-line treatment for canine epilepsy due to its efficacy, affordability, and favorable pharmacokinetics.
Silvana Alvariza   +6 more
doaj   +1 more source

Exploring the current practices of parenteral nutrition from pharmacists’ perspectives: a qualitative study [PDF]

open access: yesPharmacia
Parenteral nutrition (PN) therapy is indicated to meet patients’ nutritional needs when normal feeding is not feasible. This study was designed to explore current practices and barriers to PN from the perspective of pharmacists.
Omaima Ibrahim Saleh   +2 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy